Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities.
Boon, Lise; Ugarte-Berzal, Estefania; Vandooren, Jennifer; Opdenakker, Ghislain.
; 473(11): 1471-82, 2016 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-27234584
Design and Structural Evolution of Matrix Metalloproteinase Inhibitors.
Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions.
Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome.
Matrix metalloproteinases: regulators of the tumor microenvironment.
A personal journey with matrix metalloproteinases.
Ischemic-Reperfusion Injury Increases Matrix Metalloproteinases and Tissue Metalloproteinase Inhibitors in Fetal Sheep Brain.
Metalloprotease inhibitor profiles of human ADAM8 in vitro and in cell-based assays.
MMpI: A WideRange of Available Compounds of Matrix Metalloproteinase Inhibitors.
[Research progress on the animal models and treatment strategies of diabetic foot ulcer].